Home›Stock Screener›Biopol Chemicals›Financial Statements

Biopol Chemicals Complete Financial Statements

3 Years of Data
2026 - 2024

In FY2026, Biopol Chemicals (BIOPOL) reported revenue ₹81 Cr, net profit ₹9 Cr and EPS ₹10.83, with a net profit margin of 11.1% and ROE of 18.0%. Full financial statements from FY2024 to FY2026 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Biopol Chemicals share price screener.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 11.11% 2026 data
EBITDA Margin 17.28% 2026 data
Operating Margin 17.00% 2026 data
Return on Assets 12.86% 2026 data
Return on Equity 18.00% 2026 data

Balance Sheet Ratios

Current Ratio 11.00 2026 data
Equity Ratio 71.43% 2026 data
Asset Turnover 1.16 2026 data

BIOPOL Revenue, Net Profit & EBITDA — Year-on-Year Growth

BIOPOL YoY (March 2025 vs March 2026) — revenue +65.3%, net profit +125.0%, EBITDA +100.0%, expenses +58.1%.

Revenue Growth
+65.3%
Year-over-Year
Net Profit Growth
+125.0%
Year-over-Year
EBITDA Growth
+100.0%
Year-over-Year
Expense Growth
+58.1%
Year-over-Year
Assets Growth
+118.8%
Year-over-Year
Equity Growth
+257.1%
Year-over-Year
Operating Cash Flow Growth
-550.0%
Year-over-Year
Financing Cash Flow Growth
+575.0%
Year-over-Year

BIOPOL Income Statement — Revenue, EBITDA & Net Profit

Biopol Chemicals revenue ₹81 Cr, EBITDA ₹14 Cr, net profit ₹9 Cr, EPS ₹10.83 (2026) — net profit margin 11.1%. Compare with Biopol Chemicals valuation methods to assess whether the stock is under or overvalued.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024
Revenue 81 49 26
Expenses 68 43 21
EBITDA 14 7 4
Operating Profit Margin % 17.00% 13.00% 17.00%
Depreciation 0 0 0
Interest 2 1 0
Profit Before Tax 12 6 4
Tax 3 2 1
Net Profit 9 4 3
Earnings Per Share (₹) 10.83 5.45 3.75

BIOPOL Balance Sheet — Assets, Liabilities & Shareholders' Equity

BIOPOL total assets ₹70 Cr, total equity ₹50 Cr, total liabilities ₹ Cr (2026) — ROE 18.0%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024
ASSETS
Total Assets 70 32 18
Current Assets 55 31 17
Fixed Assets 14 0 0
Capital Work in Progress 0 0 0
Investments 0 0 0
Other Assets 55 31 17
LIABILITIES
Total Liabilities
Current Liabilities 5 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 50 14 9
Share Capital 11 8 8
Reserves & Surplus 39 6 1

BIOPOL Cash Flow Statement — Operating, Investing & Financing

Biopol Chemicals operating cash flow ₹-13 Cr, investing ₹-15 Cr, financing ₹27 Cr, net cash flow ₹-1 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024
Operating Activities -13 -2 -6
Investing Activities -15 0 -1
Financing Activities 27 4 7
Net Cash Flow -1 1 0